Tuesday 30 Apr, 2024 01:46 AM
Site map | Locate Us | Login
   Satin Creditcare spurts after Q4 PAT climbs 33% YoY    Trent rises on reporting multi-fold jump in Q4 PAT    PNB Housing rises as Q4 PAT climbs 57% YoY to Rs 439 cr    UltraTech Cement gains as Q4 PAT jumps 36% YoY to Rs 2,258 cr    KPIT Tech surges as Q4 PAT rises 6% QoQ to Rs 164 cr    Apollo Hospital drops after Advent deal    HCL Technologies Ltd leads losers in 'A' group    Balu Forge Industries Ltd leads losers in 'B' group    Volumes jump at Supreme Industries Ltd counter    Auto stocks edge lower    FMCG stocks edge lower    Real Estate shares slide    Gland Pharma gets US FDA nod for Cetrorelix Acetate    Central Bank of India rises for third straight session    UCO Bank soars 2.02% 
Saravan Stocks
       
Company News
Prism Medico & Pharmacy Ltd Industry:  Trading
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
512217 INE730E01016 25.0048318 N.A 0 14.42 148.63 0.16 10
Date Headline
14-Feb-2024 Prism Medico & Pharmacy reports standalone net profit of Rs 0.19 crore in the December 2023 quarter
06-Feb-2024 Prism Medico and Pharmacy to hold board meeting
05-Feb-2024 Prism Medico & Pharmacy Ltd - Board Meeting Intimation for Intimation Of Board Meeting.
19-Jan-2024 Prism Medico & Pharmacy Ltd - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
19-Jan-2024 Prism Medico & Pharmacy Ltd - Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
15-Jan-2024 Prism Medico & Pharmacy Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
05-Jan-2024 Prism Medico & Pharmacy Ltd - Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
05-Jan-2024 Prism Medico & Pharmacy Ltd - Compliance-57 (5) : intimation after the end of quarter
09-Nov-2023 Prism Medico & Pharmacy reports standalone net loss of Rs 0.05 crore in the September 2023 quarter
09-Nov-2023 Prism Medico & Pharmacy Ltd - Revision In Outcome Of Board Meeting Held On 08Th November 2023.
1 2 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32231583
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd